Patient choice of surgery or surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal carcinoma

Br J Surg. 2024 Jan 3;111(1):znad352. doi: 10.1093/bjs/znad352.

Thomas N Walsh^{1

2}, Natallia Kharytaniuk^{1

3}, Heidi Furlong¹, Jan Sorensen⁴, Brian D P O'Neill⁵, Oscar S Breathnach⁶, Liam Grogan⁶

¹ Department of Surgery, Royal College of Surgeons in Ireland, Connolly Hospital, Dublin, Ireland.
² Department of Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
³ Ear Institute, University College London, London, UK.
⁴ Healthcare Outcomes Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁵ Department of Radiation Oncology, Beaumont Hospital, Dublin, Ireland.
⁶ Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.

No abstract available

MeSH terms